Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Malinge

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1995
Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepamM Bourin, M Malinge
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 1, 1996
A new design of trial for hypnotics comparison: a double-blind cross-over trial with patient's preference assessment and continuation of the preferred treatmentM Bourin, M Malinge
The EMBO Journal|June 1, 1984
Reaction of cis-diamminedichloroplatinum (II) and DNA in B or Z conformationJ M Malinge, M Leng
Nucleic Acids Research|August 11, 1988
Reactivity of monofunctional cis-platinum adducts as a function of DNA sequenceJ M Malinge, M Leng
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agentsJ M Malinge, M Leng
Therapie|July 1, 1995
Provocative agents in panic disorderM Bourin, M Malinge, B Guitton
Nucleic Acids Research|February 25, 1987
Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acidsJ M Malinge, A Schwartz, M Leng
Nucleic Acids Research|February 15, 1997
Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNAC Pérez, M Leng, J M Malinge
Nucleic Acids Research|September 25, 1994
Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNAJ M Malinge, C Pérez, M Leng
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteersM Bourin, M C Colombel, M Malinge
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1995
Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepamM Bourin, M Malinge
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 1, 1996
A new design of trial for hypnotics comparison: a double-blind cross-over trial with patient's preference assessment and continuation of the preferred treatmentM Bourin, M Malinge
The EMBO Journal|June 1, 1984
Reaction of cis-diamminedichloroplatinum (II) and DNA in B or Z conformationJ M Malinge, M Leng
Nucleic Acids Research|August 11, 1988
Reactivity of monofunctional cis-platinum adducts as a function of DNA sequenceJ M Malinge, M Leng
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agentsJ M Malinge, M Leng
Therapie|July 1, 1995
Provocative agents in panic disorderM Bourin, M Malinge, B Guitton
Nucleic Acids Research|February 25, 1987
Characterization of the ternary complexes formed in the reaction of cis-diamminedichloroplatinum (II), ethidium bromide and nucleic acidsJ M Malinge, A Schwartz, M Leng
Nucleic Acids Research|February 15, 1997
Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNAC Pérez, M Leng, J M Malinge
Nucleic Acids Research|September 25, 1994
Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNAJ M Malinge, C Pérez, M Leng
Journal of Psychopharmacology (Oxford, England)|February 3, 2012
Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteersM Bourin, M C Colombel, M Malinge
Pageof 4